Matches in SemOpenAlex for { <https://semopenalex.org/work/W3117285544> ?p ?o ?g. }
- W3117285544 endingPage "100317" @default.
- W3117285544 startingPage "100317" @default.
- W3117285544 abstract "The COVID-19 death toll has involved to date more than 1 million confirmed deaths. The death rate is even higher in the obese COVID-19 patients, as a result of hypoxia, due to the interplay between adipose tissue hypoxia and obstructive sleep apnea. The discrepancy of manifestations seen in COVID-19 seems to be mediated by a differential immune response rather than a differential viral load. One of the key players of the immune response is HIF. HIF-1β is a stable constitutively expressed protein in the nucleus; and under hypoxic changes, its activity is unaffected, whereas the HIF-α subunit has a short half-life and because of its degradation by an enzyme known as propyl hydroxylase; under hypoxic conditions, propyl hydroxylase gets deactivated thus leading to the stabilization of HIF-1α. As mentioned before, HIF-1α expression is triggered by hypoxic states, this crippling condition will aggravate the pro-inflammatory characteristics of HIF-1α. The vast majority of decompensated COVID19 cases manifest with drastic lung injury and severe viral pneumonia, the infection-induced hypoxia will the existing hypoxia in obesity. This will additionally augment HIF-1α levels that will provoke the already existing cytokines' storm to fulminant. Consequently, this will directly correlate the effect of a hypoxic environment with the increase of HIF-1α level. HIFɑ exists in two main isoforms HIF-1α and HIF-2α. HIF-1α and HIF-2α act in distinct ways in how they work on different target genes. For example, HIF-2α may act on hemopoietin genes (heme-regulating genes); while HIF-1α acts on EPO. HIF-1α release seems to be markedly augmented in obesity due to adipose tissue hypoxia and obstructive sleep apnea resulting in cyclic hypoxia. HIF-1α can also be secreted by direct viral proteolytic effects. Whereas, HIF-2α is stimulated by chronic hypoxia. HIF-1α exerts detrimental effects on the immune system, characterized by unopposed pro-inflammation at the macrophages, dendritic cells, T cells, and complement levels resulting in cytokines’ storm, which is linked to the poor outcomes of COVID-19. On the other hand, HIF-2α role is regulatory and largely opposes the actions mediated by HIF-1α. In view of this, inhibiting HIF-1α release or switching its production to HIF-2α by natural products such as resveratrol or by synthetic drugs, offer a good therapeutic strategy that can prevent COVID-19 worst outcome in infected patients. The approach of breaking the vicious circle between lung damage-induced hypoxia and HIF-1α pro-inflammatory stimulant through drugs is considered to be extremely promising as a therapeutic manner to combat further deterioration of COVID19 cases." @default.
- W3117285544 created "2021-01-05" @default.
- W3117285544 creator A5004529358 @default.
- W3117285544 creator A5011499151 @default.
- W3117285544 creator A5012968227 @default.
- W3117285544 creator A5017217253 @default.
- W3117285544 creator A5019972743 @default.
- W3117285544 creator A5025181770 @default.
- W3117285544 creator A5030582927 @default.
- W3117285544 creator A5034062595 @default.
- W3117285544 creator A5036337724 @default.
- W3117285544 creator A5036856347 @default.
- W3117285544 creator A5038854348 @default.
- W3117285544 creator A5039885319 @default.
- W3117285544 creator A5039989729 @default.
- W3117285544 creator A5040541615 @default.
- W3117285544 creator A5047064514 @default.
- W3117285544 creator A5048773155 @default.
- W3117285544 creator A5050584343 @default.
- W3117285544 creator A5054715901 @default.
- W3117285544 creator A5054833730 @default.
- W3117285544 creator A5057366139 @default.
- W3117285544 creator A5059081635 @default.
- W3117285544 creator A5066513072 @default.
- W3117285544 creator A5066666357 @default.
- W3117285544 creator A5070499055 @default.
- W3117285544 creator A5070710558 @default.
- W3117285544 creator A5076653687 @default.
- W3117285544 creator A5083857051 @default.
- W3117285544 creator A5086444189 @default.
- W3117285544 creator A5087788512 @default.
- W3117285544 creator A5088458123 @default.
- W3117285544 date "2021-03-01" @default.
- W3117285544 modified "2023-09-27" @default.
- W3117285544 title "Hypoxia-inducible factor (HIF): The link between obesity and COVID-19" @default.
- W3117285544 cites W1565533127 @default.
- W3117285544 cites W1917494022 @default.
- W3117285544 cites W1948672539 @default.
- W3117285544 cites W1950282179 @default.
- W3117285544 cites W1970787934 @default.
- W3117285544 cites W1970819699 @default.
- W3117285544 cites W1974522159 @default.
- W3117285544 cites W1980601176 @default.
- W3117285544 cites W1984921150 @default.
- W3117285544 cites W1998349950 @default.
- W3117285544 cites W2027852965 @default.
- W3117285544 cites W2056259653 @default.
- W3117285544 cites W2095793094 @default.
- W3117285544 cites W2102761049 @default.
- W3117285544 cites W2105891541 @default.
- W3117285544 cites W2113689677 @default.
- W3117285544 cites W2115039765 @default.
- W3117285544 cites W2122882931 @default.
- W3117285544 cites W2137061905 @default.
- W3117285544 cites W2147576297 @default.
- W3117285544 cites W2149472502 @default.
- W3117285544 cites W2157002370 @default.
- W3117285544 cites W2160602863 @default.
- W3117285544 cites W2160664949 @default.
- W3117285544 cites W2617283302 @default.
- W3117285544 cites W2620406790 @default.
- W3117285544 cites W2623068422 @default.
- W3117285544 cites W2806025367 @default.
- W3117285544 cites W2910922160 @default.
- W3117285544 cites W2914522970 @default.
- W3117285544 cites W2964416380 @default.
- W3117285544 cites W2993397419 @default.
- W3117285544 cites W3011201358 @default.
- W3117285544 cites W3024643080 @default.
- W3117285544 cites W3036722188 @default.
- W3117285544 cites W3041494167 @default.
- W3117285544 cites W3045768066 @default.
- W3117285544 cites W3088853410 @default.
- W3117285544 cites W3092326438 @default.
- W3117285544 cites W3096262333 @default.
- W3117285544 cites W3112902030 @default.
- W3117285544 cites W836710179 @default.
- W3117285544 doi "https://doi.org/10.1016/j.obmed.2020.100317" @default.
- W3117285544 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7832240" @default.
- W3117285544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33521378" @default.
- W3117285544 hasPublicationYear "2021" @default.
- W3117285544 type Work @default.
- W3117285544 sameAs 3117285544 @default.
- W3117285544 citedByCount "27" @default.
- W3117285544 countsByYear W31172855442021 @default.
- W3117285544 countsByYear W31172855442022 @default.
- W3117285544 countsByYear W31172855442023 @default.
- W3117285544 crossrefType "journal-article" @default.
- W3117285544 hasAuthorship W3117285544A5004529358 @default.
- W3117285544 hasAuthorship W3117285544A5011499151 @default.
- W3117285544 hasAuthorship W3117285544A5012968227 @default.
- W3117285544 hasAuthorship W3117285544A5017217253 @default.
- W3117285544 hasAuthorship W3117285544A5019972743 @default.
- W3117285544 hasAuthorship W3117285544A5025181770 @default.
- W3117285544 hasAuthorship W3117285544A5030582927 @default.
- W3117285544 hasAuthorship W3117285544A5034062595 @default.
- W3117285544 hasAuthorship W3117285544A5036337724 @default.
- W3117285544 hasAuthorship W3117285544A5036856347 @default.